Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
Rans K, Charlien B, Filip A, Olivier H, Julie DH, Céderic D, Herlinde D, Benedikt E, Karolien G, Annouschka L, Nick L, Kenneth P, Carl S, Koen S, Hans V, Ben V, Steven J, Gert M. Rans K, et al. BMC Cancer. 2022 Dec 12;22(1):1294. doi: 10.1186/s12885-022-10374-0. BMC Cancer. 2022. PMID: 36503429 Free PMC article. Clinical Trial.
Salvage Radiotherapy for Prostate Cancer.
Rans K, Berghen C, Joniau S, De Meerleer G. Rans K, et al. Clin Oncol (R Coll Radiol). 2020 Mar;32(3):156-162. doi: 10.1016/j.clon.2020.01.003. Clin Oncol (R Coll Radiol). 2020. PMID: 32035581 Review.
Elective nodal radiotherapy in prostate cancer.
De Meerleer G, Berghen C, Briganti A, Vulsteke C, Murray J, Joniau S, Leliveld AM, Cozzarini C, Decaestecker K, Rans K, Fonteyne V, De Hertogh O, Bossi A. De Meerleer G, et al. Among authors: rans k. Lancet Oncol. 2021 Aug;22(8):e348-e357. doi: 10.1016/S1470-2045(21)00242-4. Lancet Oncol. 2021. PMID: 34339655 Review.
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study.
Fonteyne V, Danckaert W, Ost P, Berghen C, Vandecasteele K, Vanneste B, Rans K, Liefhooghe N, Wallaert S, Paelinck L. Fonteyne V, et al. Among authors: rans k. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231154088. doi: 10.1177/15330338231154088. Technol Cancer Res Treat. 2023. PMID: 37016933 Free PMC article. Clinical Trial.
In Regard to Zelefsky et al.
Rans K, De Meerleer G, Joniau S, Baten A, Berkovic P, Lambrecht M, Berghen C. Rans K, et al. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):910-911. doi: 10.1016/j.ijrobp.2021.02.038. Int J Radiat Oncol Biol Phys. 2021. PMID: 34089682 No abstract available.
18 results